U-Neuron Biomedical Inc. (6973)
Market Closed
16 Oct, 05:30 AM
TWSE 
JPX Primary TWSE NT$
60. 70
+1.8
+3.056%
NT$
- Market Cap
- P/E Ratio
- Div Yield
96,096 Volume
- Eps
NT$ 58.9
Previous Close Want to track 6973 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
U-Neuron Biomedical Inc. (6973) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.94B
Trailing P/E (ttm) -38.91
Forward P/E -
PEG ratio -0.39
Price/Sales (ttm) 23.73
Price/Book (mrq) 3.47
Enterprise Value/Revenue 19.66
Enterprise Value/EBITDA -39.81
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 148.03K
Average volume (90 days) 168.71K
Price summary
52-Week low 31.3
52-Week high 70.2
Beta -
50-Day moving average 55.11
200-Day moving average 40.17
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 533:500
Last split Date 20 Jun 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.61%
Operating margin -0.71%
Operational effectiveness
Return on assets -0.08%
Return on equity -0.09%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.54
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.56
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 15.43
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 10.4%
Book value per share (mrq) 17.5
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
